Skip to content

Study on the effect and mechanism of cognitive-cup-tapping-balance-training on fall prevention in community Parkinson's patients: a randomized controlled trial

Study on the effect and mechanism of cognitive-cup-tapping-balance-training on fall prevention in community Parkinson's patients: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038852
Enrollment
Unknown
Registered
2020-10-07
Start date
2020-10-20
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

dual task training group :cognitive-cup-tapping balance training
single task training group:-cup-tapping balance training

Sponsors

Shanghai University of Sport
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for Parkinson's subjects: with a definite diagnosis of Parkinson's disease and a history of more than 6 months after diagnosis; Aged between 40 and 80 years; Hoehn-yahr grades 1 to 4 (the hoehn-Yahr grades here are modified grades, ranging from 0 to 5); the condition was stable after taking anti-Parkinson's drugsAble to walk independently at least 30m with or without walking aids; Normal vision. 2. Inclusion criteria for non-Parkinson's subjects: Aged 40-80 years; Walking independently more than 30m with or without walking aids; Normal vision.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for Parkinson's subjects: MMSE score < 24; have undergone neurosurgical procedures such as deep brain stimulation (DBS); with musculoskeletal diseases, cardiopulmonary diseases or other neurological diseases that may affect balance or exercise; with lower extremity peripheral neuropathy; with severe hearing or language impairment who cannot understand commands and express needs; with impaired visual function (such as significantly reduced color resolution, contrast sensitivity, spatial resolution, etc.) or visual hallucinations after medication. 2. Exclusion criteria for non-Parkinson's participate: Parkinson's disease; Cognitive impairment, MMSE score < 24; situations that may affect balance or movement, such as those associated with musculoskeletal disease, cardiopulmonary disease or other neurological diseases; Participates with peripheral neuropathy of lower extremity; Participates with severe hearing or language impairment who cannot understand instructions and express needs; Participates accompanied by decreased visual function (such as significantly reduced color vision resolution, contrast sensitivity, spatial resolution, etc.)

Design outcomes

Primary

MeasureTime frame
fall history;

Secondary

MeasureTime frame
UPDRS-III;fall risk;cognition;Frontal lobe oxygenated hemoglobin concentration;

Countries

china

Contacts

Public ContactJiaHan

Shanghai University of Sport

Jia.Han@canberra.edu.au+86 18521777440

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026